Riskpilot← Back to searchSign inGet full accessAb Jakobstads Medicenter
OYActiveY-tunnus 0573820-7Stenbrännvägen 44Medical specialists activities · NACE 8622Est. 1984— employees
Revenue 2024
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2024
—
| Revenue | — | — |
| EBITDA | — | — |
| Net profit | — | — |
| Total assets | — | — |
| Equity | — | — |
| Employees | — | — |
Legal name
Ab Jakobstads Medicenter
Y-tunnus number
0573820-7
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
6. syyskuuta 1984
Share capital
EUR 11 269
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Bolagets verksamhetsområde är medicinsk och fysioterapeutiskt vård samt utförande av medicinska undersökningar och drivande av laboratorieverksamhet. Bolaget kan hyra ut fastigheter, lös egendom och arbetskraft. Bolaget kan äga, besitta och bedriva handel med medicinsk utrustning, fast egendom och värdepapper.
Address
Stenbrännvägen 44
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 95 | 96 | 101 | — | — |
| Staff expenses | −13 | −13 | −14 | — | — |
| EBITDA | 42 | 37 | 41 | — | — |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | 42 | 37 | 41 | — | — |
| Net financials | −7 | 2 | 3 | — | — |
| Profit before tax | 35 | 39 | 44 | — | — |
| Tax | 2 | 8 | 9 | — | — |
| Net profit | 32 | 32 | 35 | — | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 941 | 915 | 893 | — | — |
| Equity | 909 | 886 | 866 | — | — |
| Long-term debt | — | — | — | — | — |
| Short-term debt | 32 | 29 | 27 | — | — |
| Total debt | 32 | 29 | 27 | — | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
RG Chief Executive Officer | Chief Executive Officer | 2014 |
PN | Audit | 2014 |
AM Deputy auditor | Deputy auditor | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2014 | |
| Board of Directors | 2014 | |
| Board of Directors | 2014 | |
| Board of Directors | 2014 | |
| Board of Directors | 2014 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ab Jakobstads Medicenter also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Gustaf Nyman | Chief Executive Officer | 0 companies |
| Peter Nils Johan Boström | Audit | 0 companies |
| Anders Mikael Mattsson | Deputy auditor | 0 companies |
| Per-Erik Wingren | Board of Directors | 0 companies |
| Johan Mats Alfred Nyman | Board of Directors | 0 companies |
| Margita Anna-Maria Nyman | Board of Directors | 0 companies |
| Rolf Voldmar Alfred Nyman | Board of Directors | 0 companies |
| Juhani Antero Matias Aho | Board of Directors | 0 companies |